Assignee
CHATTERTON JON E
US·9 granted patents·2 pending applications·47 citations·filing 2009–2012
Top patents by PatentIndex Score
11 records- 0197US8268798B2Low density lipoprotein receptor-mediated siRNA deliveryCHATTERTON JON E·Filed 2011·Granted Sep 18, 2012·34 cites·10 claims
- 0289US8399653B2Transferrin/transferrin receptor-mediated siRNA deliveryCHATTERTON JON E·Filed 2011·Granted Mar 19, 2013·8 cites·6 claims
- 0383US8664375B2Interfering RNA delivery system and uses thereofCHATTERTON JON E·Filed 2010·Granted Mar 4, 2014·4 cites·8 claims
- 0475US8569258B2Low density lipoprotein receptor-mediated siRNA deliveryCHATTERTON JON E·Filed 2012·Granted Oct 29, 2013·1 cites·12 claims
- 0570US9173896B2RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditionsCHATTERTON JON E·Filed 2009·Granted Nov 3, 2015·0 cites·14 claims
- 0666US8471000B2RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesisCHATTERTON JON E·Filed 2012·Granted Jun 25, 2013·0 cites·1 claims
- 0760US8754202B2RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesisCHATTERTON JON E·Filed 2011·Granted Jun 17, 2014·0 cites·1 claims
- 0857US8168609B2RNAi-mediated inhibition of Rho kinase for treatment of ocular disordersCHATTERTON JON E·Filed 2010·Granted May 1, 2012·0 cites·15 claims
- 0957US2012178794A1RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular DisordersCHATTERTON JON E·Filed 2012·Application pending·0 cites
- 1053US8865670B2RNAi-related inhibition of TNFα signaling pathway for treatment of glaucomaCHATTERTON JON E·Filed 2011·Granted Oct 21, 2014·0 cites·14 claims
- 1153US2012077864A1Rnai-mediated inhibition of gremlin for treatment of iop-related conditionsCHATTERTON JON E·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →